S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
The Growing Case For A Major Stock Market Correction
United Health’s Guidance Gives Investors A Chill 
The Top 3 Blue Chip Stocks to Bank on Long-Term
3 Top Energy Stocks to Buy in 2022
New York AG says Trump's company misled banks, tax officials
German leader champions new tack on climate at Davos event
Colorado coal town grapples with future as plant shuts down
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
The Growing Case For A Major Stock Market Correction
United Health’s Guidance Gives Investors A Chill 
The Top 3 Blue Chip Stocks to Bank on Long-Term
3 Top Energy Stocks to Buy in 2022
New York AG says Trump's company misled banks, tax officials
German leader champions new tack on climate at Davos event
Colorado coal town grapples with future as plant shuts down
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
The Growing Case For A Major Stock Market Correction
United Health’s Guidance Gives Investors A Chill 
The Top 3 Blue Chip Stocks to Bank on Long-Term
3 Top Energy Stocks to Buy in 2022
New York AG says Trump's company misled banks, tax officials
German leader champions new tack on climate at Davos event
Colorado coal town grapples with future as plant shuts down
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
The Growing Case For A Major Stock Market Correction
United Health’s Guidance Gives Investors A Chill 
The Top 3 Blue Chip Stocks to Bank on Long-Term
3 Top Energy Stocks to Buy in 2022
New York AG says Trump's company misled banks, tax officials
German leader champions new tack on climate at Davos event
Colorado coal town grapples with future as plant shuts down
OTCMKTS:AXIM

AXIM Biotechnologies Stock Forecast, Price & News

$0.23
+0.01 (+4.50%)
(As of 01/19/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.23
▼
$0.27
50-Day Range
$0.22
▼
$0.48
52-Week Range
$0.22
▼
$1.22
Volume
282,650 shs
Average Volume
225,752 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive AXIM News and Ratings via Email

Sign-up to receive the latest news and ratings for AXIM Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.


AXIM Biotechnologies logo

About AXIM Biotechnologies

AXIM Biotechnologies, Inc. operates as a biotechnology company. It focuses in the research, development and production of pharmaceutical, nutraceutical, cosmetic and genetically controlled botanical products. The firm also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand. The company was founded on November 18, 2010 and is headquartered in San Diego, CA.

Headlines

Ghana Health Service Explains Axim Hospital Issue
January 7, 2022 |  msn.com
CDC Publishes AXIM® Biotechnologies-Sponsored Study on COVID-19 Neutralizing Antibodies
December 21, 2021 |  finance.yahoo.com
AXIM Biotechnologies Applauds FDA's Recent COVID-19 Test Policies to Support Rapid Neutralizing Antibody Tests
November 18, 2021 |  finance.yahoo.com
AXIM Biotechnologies Partners with Arizona State University to Determine Antibody Levels Against COVID-19
November 16, 2021 |  finance.yahoo.com
AXIM Biotechnologies’ Development of Rapid Test for COVID-19 Neutralizing Antibodies is Cited to Demonstrate over 90% Sensitivity and 100% Specificity
November 9, 2021 |  finance.yahoo.com
AXIM Biotechnologies Appoints Clinical Research and DED Expert Dr. Michael E. Stern to its Medical Advisory Board
November 2, 2021 |  finance.yahoo.com
UAB dean named to advisory board of AXIM Biotechnologies
October 25, 2021 |  bizjournals.com
AXIM Biotechnologies Appoints Dry Eye Disease Expert and Accomplished Optometrist Dr. Kelly K. Nichols to its Medical Advisory Board
October 20, 2021 |  finance.yahoo.com
AXIM® Biotechnologies Develops Next Generation of its Rapid Neutralizing Antibody Test for COVID-19
October 12, 2021 |  finance.yahoo.com
AXIM® Biotechnologies Appoints Leading US Ophthalmic Surgeon and Researcher Dr. Henry D. Perry to its Medical Advisory Board
October 11, 2021 |  finance.yahoo.com
AXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board
October 5, 2021 |  finance.yahoo.com
AXIM® Biotechnologies Appoints Joseph Tauber, MD, Chief Medical Officer and Chairman of its Medical Advisory Board
September 21, 2021 |  finance.yahoo.com
Upper Axim Nkosuohemaa Destooled
September 17, 2021 |  msn.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:AXIM
Previous Symbol
CUSIP
N/A
CIK
1514946
Web
aximbiotech.com
Phone
(858) 923-4422
Fax
N/A
Employees
7
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

0.80 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












AXIM Biotechnologies (OTCMKTS:AXIM) Frequently Asked Questions

How has AXIM Biotechnologies' stock price been impacted by Coronavirus (COVID-19)?

AXIM Biotechnologies' stock was trading at $0.1781 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AXIM shares have increased by 30.3% and is now trading at $0.2321.
View which stocks have been most impacted by COVID-19.

Are investors shorting AXIM Biotechnologies?

AXIM Biotechnologies saw a increase in short interest in the month of December. As of December 15th, there was short interest totaling 27,300 shares, an increase of 47.6% from the November 30th total of 18,500 shares. Based on an average daily trading volume, of 285,300 shares, the short-interest ratio is currently 0.1 days.
View AXIM Biotechnologies' Short Interest.

Who are AXIM Biotechnologies' key executives?

AXIM Biotechnologies' management team includes the following people:
  • John W. Huemoeller, President, Chief Executive Officer & Director
  • Robert T. Malasek, Chief Financial Officer & Secretary
  • Joseph Tauber, Chief Medical Officer
  • Jeffrey A. Busby, Senior Vice President-Business Development

What other stocks do shareholders of AXIM Biotechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AXIM Biotechnologies investors own include (CGC), Cronos Group (CRON), (APHA), Tilray (TLRY), KushCo (KSHB), Aurora Cannabis (ACB), Curaleaf (CURLF), Charlotte's Web (CWBHF), Fulcrum Therapeutics (FULC) and Alibaba Group (BABA).

What is AXIM Biotechnologies' stock symbol?

AXIM Biotechnologies trades on the OTCMKTS under the ticker symbol "AXIM."

How do I buy shares of AXIM Biotechnologies?

Shares of AXIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AXIM Biotechnologies' stock price today?

One share of AXIM stock can currently be purchased for approximately $0.23.

How many employees does AXIM Biotechnologies have?

AXIM Biotechnologies employs 7 workers across the globe.

What is AXIM Biotechnologies' official website?

The official website for AXIM Biotechnologies is aximbiotech.com.

How can I contact AXIM Biotechnologies?

The company can be reached via phone at (858) 923-4422.


This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.